Zymeworks Inc. (NYSE: ZYME) had its price target lowered by analysts at Citigroup Inc. from $17.00 to $16.00. They now have a "buy" rating on the stock.
Zymeworks Inc. (NYSE: ZYME) had its price target lowered by analysts at Wells Fargo & Company from $14.00 to $12.00. They now have an "overweight" rating on the stock.
Zymeworks Inc. (NYSE:ZYME) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
Lost Money on Zymeworks Inc.(ZYME)? Contact Levi & Korsinsky Regarding an Ongoing Investigation
Zymeworks Inc. (ZYME) Reports Q1 Loss, Misses Revenue Estimates [Yahoo! Finance]